Role of GastriCare in Digestive wellbeing
Phase 2
Completed
- Conditions
- Health Condition 1: null- Subjects who have clinical symptoms of dyspepsia, upper abdominal pain, heart burn, bloating, indigestion, flatulence, abdominal distension, belching and fullness after meal
- Registration Number
- CTRI/2018/04/013249
- Lead Sponsor
- The Himalaya Drug Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
1 Subjects of both sexes in the age group of 18 - 60 years, with gastric problems.
2 Subjects who have clinical symptoms of dyspepsia, upper abdominal pain, heart burn, bloating, indigestion, flatulence, abdominal distension, belching and fullness after meal.
3 Subjects willing to give written informed consent.
4 Subjects who have not participated in similar kind of study in last 4 weeks.
Exclusion Criteria
1 Subjects with established hypertension, renal, hepatic or cardiac failure
2 Endocrine disorders
3 Use of prescription medication to treat gastric problems
4 Pregnant & lactating women.
5 Not willing to sign informed consent form.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method